FDA inspection
Targanta Therapeutics, Corp.: FDA inspection ending Aug 29, 2008
FDA inspection 541359 · Voluntary Action Indicated (VAI) · Indianapolis, IN
Key facts
| Inspection ID | 541359 |
|---|---|
| Firm | Targanta Therapeutics, Corp. |
| FEI number | 3006849644 |
| Address | 225 S East St Ste 390 |
| City | Indianapolis |
| State | IN |
| ZIP | 46202-4061 |
| Fiscal year | 2008 |
| Inspection end date | Aug 29, 2008 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data